TNBC: Updated Efficacy Results From IMpassion130

(4:47)

Updated Efficacy and Safety from ANCHOR (OP-104) Study of Melflufen

(3:53)

Updated Efficacy/Safety Results of MajesTEC-1 (Teclistamab) at ASCO 2022

(11:22)

Updated efficacy and safety of anti-BCMA CAR-T for the treatment of R/R AL amyloidosis

(3:23)

Safety \u0026 efficacy of obe-cel in R/R ALL: updated findings from the FELIX trial

(1:7)

Updated Efficacy and Safety Results of the Phase 3 CANDOR study

(4:32)

Updated safety and efficacy of BMS-986393 in patients with R/R myeloma and 1-3 prior LOT

(1:30)

Cancer, ivermectin thalidomide and vit D

(14:11)

Metabolic reset

(18:27)

Bill Gates on Trump, Elon, and the Next Pandemic

(13:57)

Accelerating Toward Curing Myeloma: New Data, New Agents, and Evolving Treatment Paradigm

(2:47:42)

Research opportunities

(18:50)

My winter virus

(10:43)

Jon Stewart \u0026 Hakeem Jeffries Discuss the Democratic Strategy During Trump’s Second Term

(1:10:10)

CDISC SDTM ADaM Online Training✔ Clinical SAS Programming Training For Beginners

(3:28:1econd)

Fen ben for cancer?

(26:12)

Off-the-shelf Immune Drug for Aggressive Multiple Myeloma: Teclistamab

(49:38)

Dr. Shah on Updated Efficacy of JNJ-4528 in Relapsed/Refractory Myeloma

(2:4)

02/09/2025 - Sunday School - Pastor Tommie A Harsley III, J.D.

(57:27)

Updated efficacy data on glofitamab step-up dosing in NHL

(2:18)

Zanubrutinib in mantle cell lymphoma: updated safety and efficacy data

(55)

Updated Efficacy Results for Avelumab in Metastatic Urothelial Carcinoma

(1:10)

Updated analysis of the MAIA trial: long-term safety and efficacy data

(2:37)

Negative vaccine efficacy

(13:56)

Updates from LINKER-MM1: safety and efficacy of linvoseltamab in patients with R/R multiple myeloma

(4:)

Updated overall efficacy and safety of selpercatinib in patients with RET fusion+ NSCLC

(2:52)

Updates on Efficacy/Safety Results from MonumenTAL-1 (Talquetamab) in RRMM patients

(15:21)

An update on the MajesTEC-1 trial: the efficacy of less frequent dosing of teclistamab in RRMM

(34)

Updated Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Clinical Trials

(3:18)

Updated results from the MOMENTUM study assessing the efficacy of momelotinib in MF

(1:24)